$MNLO VYNE Therapeutics Inc. Insider Trading

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

CIK Number: 0001566044
IRS Number: 453757789
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MNLO
Company Address: 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER 08807
Phone number: 650-486-1416
Former name: Tigercat Pharma, Inc., date of change: 2013-01-04
Former name: Menlo Therapeutics, Inc., date of change: 2017-07-28

VYNE Therapeutics Inc. Latest Insider Transactions

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 07 2021	MNLO	VYNE Therapeutics ...	PERCEPTIVE ADVISORS LLC	10% Owner	Sell	S	3.67	1,000,000	3,670,000	5,773,954	6.8 M to 5.8 M (-14.76 %)
Apr 02 2021	MNLO	VYNE Therapeutics ...	Wiley Matthew T.	Chief Commercial Of ...	Payment of Exercise	F	6.84	2,573	17,599	114,397	117 K to 114.4 K (-2.20 %)
Apr 02 2021	MNLO	VYNE Therapeutics ...	Stuart Iain	Chief Scientific Of ...	Payment of Exercise	F	6.84	1,945	13,304	98,833	100.8 K to 98.8 K (-1.93 %)
Apr 02 2021	MNLO	VYNE Therapeutics ...	Saik Andrew	Chief Financial Off ...	Payment of Exercise	F	6.84	762	5,212	113,451	114.2 K to 113.5 K (-0.67 %)
Apr 02 2021	MNLO	VYNE Therapeutics ...	Harsch Mutya	Chief Legal Officer ...	Payment of Exercise	F	6.84	1,765	12,073	108,873	110.6 K to 108.9 K (-1.60 %)
Apr 02 2021	MNLO	VYNE Therapeutics ...	Domzalski David	President and CEO	Payment of Exercise	F	6.84	6,316	43,201	473,517	479.8 K to 473.5 K (-1.32 %)
Mar 16 2021	MNLO	VYNE Therapeutics ...	LEPORE PATRICK G	Director	Buy	P	7.41	12,500	92,563	25,000	12.5 K to 25 K (+100.00 %)
Feb 24 2021	MNLO	VYNE Therapeutics ...	Wiley Matthew T.	Chief Commercial Of ...	Option Exercise	A	8.33	64,575	537,910	64,575
Feb 24 2021	MNLO	VYNE Therapeutics ...	Wiley Matthew T.	Chief Commercial Of ...	Grant	A	0.00	27,675	0	116,970	89.3 K to 117 K (+30.99 %)
Feb 24 2021	MNLO	VYNE Therapeutics ...	Stuart Iain	Chief Scientific Of ...	Option Exercise	A	8.33	68,162	567,789	68,162
Feb 24 2021	MNLO	VYNE Therapeutics ...	Stuart Iain	Chief Scientific Of ...	Grant	A	0.00	29,213	0	100,778	71.6 K to 100.8 K (+40.82 %)
Feb 24 2021	MNLO	VYNE Therapeutics ...	Wiley Matthew T.	Chief Commercial Of ...	Option Exercise	A	8.33	64,575	537,910	64,575
Feb 24 2021	MNLO	VYNE Therapeutics ...	Wiley Matthew T.	Chief Commercial Of ...	Grant	A	0.00	27,675	0	116,970	89.3 K to 117 K (+30.99 %)
Feb 24 2021	MNLO	VYNE Therapeutics ...	Saik Andrew	Chief Financial Off ...	Option Exercise	A	8.33	68,162	567,789	68,162
Feb 24 2021	MNLO	VYNE Therapeutics ...	Saik Andrew	Chief Financial Off ...	Grant	A	0.00	29,213	0	114,213	85 K to 114.2 K (+34.37 %)

View all VYNE Therapeutics Inc. insider transactions.